Standardization of pectoral species no. 2: current state and prospects
- Authors: Chevidaev V.V.1, Bokov D.O.1,2, Samylina I.A.2
-
Affiliations:
- Sechenov First Moscow State Medical University
- Federal Research Center of Nutrition, Biotechnology and Food Safety
- Issue: Vol 21, No 5-6 (2021)
- Pages: 141-149
- Section: Pharmacy
- URL: https://bakhtiniada.ru/2410-3764/article/view/105871
- DOI: https://doi.org/10.55531/2072-2354.2021.21.3.141-149
- ID: 105871
Cite item
Full Text
Abstract
Nowadays, diseases of the respiratory system are a common problem for national and global healthcare. The drugs of synthetic and natural origin, intended for the prevention and treatment of these diseases, are available on the pharmaceutical market. The latter are mainly represented by herbal medicinal products, among which mixture herbal products occupy a special place. Pectoral species No. 2 is a multicomponent herbal medicinal products used for diseases of the upper respiratory tract, it includes coltsfoot leaves (40%), plantain leaves (30%), and licorice roots (30%). It is produced in the form of powder and is dispensed in packs and filter sachet. On the basis of information and analytical research, some approaches to the standardization of pectoral species No. 2 are developed in this study. Currently, the infusion is the main dosage form of pectoral species No. 2; water-soluble biologically active compounds are fully extracted by water and are responsible for the manifested pharmacological effects of pectoral species No. 2 (polysaccharides and triterpene compounds). The development of modern regulatory documentation for complex herbal preparations (mixture herbal products) should be carried out taking into account scientifically based data and harmonized requirements. Additional experimental studies are required to substantiate the indicators and standards of identity and good quality of pectoral species No. 2. Modern regulatory documentation for pharmaceutical substances of plant origin and mixture herbal products made of them (including pectoral species No. 2) should include sections that take into account the principle of “raw material-to-drug standardization” and methods that can be used in research laboratories with various material and technical support.
Full Text
##article.viewOnOriginalSite##About the authors
Vladimir V. Chevidaev
Sechenov First Moscow State Medical University
Author for correspondence.
Email: vovchev@rambler.ru
Postgraduate student, Department of Pharmaceutical Sciences, Institute of Pharmacy named after A.P. Nelyubin
Russian Federation, MoscowDmitry O. Bokov
Sechenov First Moscow State Medical University; Federal Research Center of Nutrition, Biotechnology and Food Safety
Email: bokov_d_o@staff.sechenov.ru
Candidate of Pharmaceutical Sciences, Associate Professor, Department of Pharmaceutical Sciences, Institute of Pharmacy named after A.P. Nelyubin
Russian Federation, Moscow; MoscowIrina A. Samylina
Federal Research Center of Nutrition, Biotechnology and Food Safety
Email: samylina_i_a@staff.sechenov.ru
Doctor of Pharmaceutical Sciences, Corresponding Member RAS, Professor, Department of Pharmaceutical Sciences, Institute of Pharmacy named after A.P. Nelyubin
Russian Federation, MoscowReferences
- Analiticheskiy otchet. Farmatsevticheskiy rynok Rossii: oktyabr’ 2020 [Internet]. DSM Group. Available from: https://dsm.ru/marketing/free-information/analytic-reports. (In Russ.)
- Boyko NN, Bondarev AV, Zhilyakova ET, et al. Fitopreparaty, analiz farmatsevticheskogo rynka Rossiyskoy Federatsii. Nauchnye rezul’taty biomeditsinskikh issledovaniy. 2017;3(4):1–9. (In Russ.). doi: 10.18413/2313-8955-2017-3-4-30-38
- Gosudarstvennyy reestr lekarstvennykh sredstv [Internet]. Available from: https://grls.rosminzdrav.ru. (In Russ.)
- Gosudarstvennaya farmakopeya Rossiiskoi Federatsii. XIV ed. Moscow; 2018. (In Russ.)
- Supotnitskiy MV. Novel coronavirus SARS-COV-2 in the context of global epidemiology of coronavirus infections. Journal of NBC Protection Corps. 2020;4(1):32–65. (In Russ.). doi: 10.35825/2587-5728-2020-4-1-32-65
- Trineeva OV, Slivkin AI. Determination of simple sugars in medicinal plant materials by the method of high-performance thin-layer chromatography (for example, the fruits of Sea buckthorn L. and Nettle leaves L.). Khimiya rastitel’nogo syr’ya. 2020;(1):215–222. (In Russ.). doi: 10.14258/jcprm.2020015122
- Chevidaev VV, Bokov DO, Samylina IA. Carbohydrate composition of polysaccharides in pectorales species No. 2. Farmatsiya. 2021;70(2):11–17. (In Russ.). doi: 10.29296/25419218-2021-02-02
- Adom MB, Taher M, Mutalabisin MF, et al. Chemical constituents and medical benefits of Plantago major. Biomed Pharmacother. 2017;96:348–360. doi: 10.1016/j.biopha. 2017.09.152
- Brovchenko BV, Ermakova VA, Bokov DO, et al. Validation of an HPLC-UV procedure for determining the glycyrrhizic acid content in licorice roots. Pharmaceutical Chemistry Journal. 2020;53(12):1168–1173. doi: 10.1007/s11094-020-02142-w
- Chen S, Dong L, Quan H, et al. A review of the ethnobotanical value, phytochemistry, pharmacology, toxicity and quality control of Tussilago farfara L. (coltsfoot). J Ethnopharmacol. 2021;267:113478. doi: 10.1016/j.jep.2020.113478
- Gao X, Wang W, Wei S, Li W. Review of pharmacological effects of Glycyrrhiza radix and its bioactive compounds. Zhongguo Zhong Yao Za Zhi. 2009;34(21):2695–2700. (In Chinese)
- Haddadian K, Haddadian K, Zahmatkash M, et al. A review of Plantago plant. Indian journal of traditional knowledge. 2014;13(4):681–685.
- Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–1300. doi: 10.1016/S0140-6736(17)33293-2
- Najafian Y, Hamedi SS, Farshchi MK, Feyzabadi Z. Plantago major in Traditional Persian Medicine and modern phytotherapy: a narrative review. Electron Physician. 2018;10(2):6390–6399. doi: 10.19082/6390
- Nazarizadeh A, Mikaili P, Moloudizargari M, et al. Therapeutic uses and pharmacological properties of Plantago major L. and its active constituents. J Basic Appl Sci Res. 2013;3(9):212–221.
- Nikiforov LN, Krivoshchekov SV, Kolomiets NE, et al. Development of parameters for standardization of duckweed (Lemna Minor L.) raw material. Drug development and registration. 2021;10(1):74–81. (In Russ.). doi: 10.33380/2305-2066-2021-10-1-74-81
- Samuelsen AB. The traditional uses, chemical constituents and biological activities of Plantago major L. A review. J Ethnopharmacol. 2000;71(1–2):1–21. doi: 10.1016/S0378-8741(00)00212-9
- Shen XP, Xiao PG, Liu CX. Research and application of Radix Glycyrrhizae. Asian J Pharmacodyn Pharmacokinet. 2007;7(3):181–200.
- World health statistics 2020: monitoring health for the SDGs, sustainable development goals. WHO. 2020.
- Xue SY, Li ZY, et al. Metabolic fingerprinting investigation of Tussilago farfara L. by GC–MS and multivariate data analysis. Biochemical Systematics and Ecology. 2012;41:6–12. doi: 10.1016/j.bse.2011.11.003
- Zhi HJ, Qin XM, Sun HF, et al. Metabolic fingerprinting of Tussilago farfara L. using 1H-NMR spectroscopy and multivariate data analysis. Phytochem Anal. 2012;23(5):492–501. doi: 10.1002/pca.2346
Supplementary files
